Cargando…

(1105) Multisystem Inflammatory Syndrome in a Pediatric Heart Transplant Recipient: A Case Report

INTRODUCTION: Multisystem inflammatory syndrome in children (MIS-C) is an inflammatory reaction that occurs weeks after SARS-CoV-2 infection. Solid organ transplant recipients may be protected due to immunosuppression, but this is not yet established in the literature. CASE REPORT: A 13-month-old ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Shibbani, K., Staron-Ehlinger, M.L., Raskin, A., Beasley, G.S., Khan, R.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068061/
http://dx.doi.org/10.1016/j.healun.2023.02.1316
_version_ 1785018607250440192
author Shibbani, K.
Staron-Ehlinger, M.L.
Raskin, A.
Beasley, G.S.
Khan, R.S.
author_facet Shibbani, K.
Staron-Ehlinger, M.L.
Raskin, A.
Beasley, G.S.
Khan, R.S.
author_sort Shibbani, K.
collection PubMed
description INTRODUCTION: Multisystem inflammatory syndrome in children (MIS-C) is an inflammatory reaction that occurs weeks after SARS-CoV-2 infection. Solid organ transplant recipients may be protected due to immunosuppression, but this is not yet established in the literature. CASE REPORT: A 13-month-old male status post heart transplant for ACTC1 gene-positive dilated cardiomyopathy had a post-operative course complicated by rhinovirus/enterovirus, respiratory syncytial virus, and norovirus infections within the first two months. He then presented at 11 weeks post-transplant with high fevers, macular rash, emesis, and diarrhea in the setting of SARS-CoV-2 exposure three weeks prior. Viral panel was negative for active infections, but SARS-CoV-2 antibodies were positive. He developed a mild troponin leak and rising inflammatory markers, ferritin, D-dimer, and NT-proBNP, meeting clinical criteria for MIS-C. No cardiac dysfunction or coronary dilation was present on 2D echocardiography. Tacrolimus levels had large fluctuations in the first three days but later stabilized. Intravenous immunoglobulin, steroids, and anakinra were given with clinical improvement and rapid normalization of laboratory findings, allowing discharge from the hospital in one week. Repeat echocardiogram 10 days after discharge was stable. SUMMARY: There is a paucity of MIS-C cases in pediatric solid organ transplant recipients, with only one liver transplant recipient described in the literature. We hypothesize chronic immunosuppression protects against inflammatory reactions, supported by the fact that Kawasaki disease is also not described in transplant recipients. To our knowledge, this is the first reported MIS-C case in a pediatric heart transplant recipient. Recent viral infections may have led to immune system activation that allowed development of MIS-C. The patient has demonstrated good response to anti-inflammatory therapy; however, close follow up for long-term sequelae is warranted.
format Online
Article
Text
id pubmed-10068061
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-100680612023-04-03 (1105) Multisystem Inflammatory Syndrome in a Pediatric Heart Transplant Recipient: A Case Report Shibbani, K. Staron-Ehlinger, M.L. Raskin, A. Beasley, G.S. Khan, R.S. J Heart Lung Transplant Article INTRODUCTION: Multisystem inflammatory syndrome in children (MIS-C) is an inflammatory reaction that occurs weeks after SARS-CoV-2 infection. Solid organ transplant recipients may be protected due to immunosuppression, but this is not yet established in the literature. CASE REPORT: A 13-month-old male status post heart transplant for ACTC1 gene-positive dilated cardiomyopathy had a post-operative course complicated by rhinovirus/enterovirus, respiratory syncytial virus, and norovirus infections within the first two months. He then presented at 11 weeks post-transplant with high fevers, macular rash, emesis, and diarrhea in the setting of SARS-CoV-2 exposure three weeks prior. Viral panel was negative for active infections, but SARS-CoV-2 antibodies were positive. He developed a mild troponin leak and rising inflammatory markers, ferritin, D-dimer, and NT-proBNP, meeting clinical criteria for MIS-C. No cardiac dysfunction or coronary dilation was present on 2D echocardiography. Tacrolimus levels had large fluctuations in the first three days but later stabilized. Intravenous immunoglobulin, steroids, and anakinra were given with clinical improvement and rapid normalization of laboratory findings, allowing discharge from the hospital in one week. Repeat echocardiogram 10 days after discharge was stable. SUMMARY: There is a paucity of MIS-C cases in pediatric solid organ transplant recipients, with only one liver transplant recipient described in the literature. We hypothesize chronic immunosuppression protects against inflammatory reactions, supported by the fact that Kawasaki disease is also not described in transplant recipients. To our knowledge, this is the first reported MIS-C case in a pediatric heart transplant recipient. Recent viral infections may have led to immune system activation that allowed development of MIS-C. The patient has demonstrated good response to anti-inflammatory therapy; however, close follow up for long-term sequelae is warranted. Published by Elsevier Inc. 2023-04 2023-04-03 /pmc/articles/PMC10068061/ http://dx.doi.org/10.1016/j.healun.2023.02.1316 Text en Copyright © 2023 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Shibbani, K.
Staron-Ehlinger, M.L.
Raskin, A.
Beasley, G.S.
Khan, R.S.
(1105) Multisystem Inflammatory Syndrome in a Pediatric Heart Transplant Recipient: A Case Report
title (1105) Multisystem Inflammatory Syndrome in a Pediatric Heart Transplant Recipient: A Case Report
title_full (1105) Multisystem Inflammatory Syndrome in a Pediatric Heart Transplant Recipient: A Case Report
title_fullStr (1105) Multisystem Inflammatory Syndrome in a Pediatric Heart Transplant Recipient: A Case Report
title_full_unstemmed (1105) Multisystem Inflammatory Syndrome in a Pediatric Heart Transplant Recipient: A Case Report
title_short (1105) Multisystem Inflammatory Syndrome in a Pediatric Heart Transplant Recipient: A Case Report
title_sort (1105) multisystem inflammatory syndrome in a pediatric heart transplant recipient: a case report
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068061/
http://dx.doi.org/10.1016/j.healun.2023.02.1316
work_keys_str_mv AT shibbanik 1105multisysteminflammatorysyndromeinapediatrichearttransplantrecipientacasereport
AT staronehlingerml 1105multisysteminflammatorysyndromeinapediatrichearttransplantrecipientacasereport
AT raskina 1105multisysteminflammatorysyndromeinapediatrichearttransplantrecipientacasereport
AT beasleygs 1105multisysteminflammatorysyndromeinapediatrichearttransplantrecipientacasereport
AT khanrs 1105multisysteminflammatorysyndromeinapediatrichearttransplantrecipientacasereport